Goldman Sachs now forecasts the Federal Reserve will cut interest rates twice in 2025, compared to its earlier estimate of three cuts, citing persistent inflation and a robust labor market. The anticipated cuts are expected in June and December, with an additional reduction in 2026. This would lower the Fed's terminal rate to 3.5%-3.75% from the current 4.25%-4.5%.
The revised outlook follows stronger-than-expected December nonfarm payrolls data, which intensified speculation that the Fed may slow its pace of rate cuts. This development caused significant losses on Wall Street, reflecting investor concerns about monetary policy adjustments.
While the Fed reduced rates by 1% in 2024, it signaled a slower trajectory for cuts moving forward. Goldman Sachs adjusted its projections from four to two cuts in 2025, emphasizing challenges posed by inflationary pressures and a strong labor market. Analysts noted uncertainty about the timing of these cuts, given the strength of U.S. economic indicators.
The investment bank also highlighted potential economic disruptions under President Donald Trump’s incoming administration, particularly from proposed import tariffs targeting major trading partners like China. While these tariffs are expected to raise costs for American importers, Goldman Sachs believes the resulting inflation will be insufficient to trigger additional rate hikes or destabilize financial markets.
Despite concerns over fiscal and immigration policies, Goldman Sachs remains cautiously optimistic, maintaining a slightly more dovish stance than market expectations. The bank emphasized that upcoming economic data and trade policies will likely shape the Fed’s monetary decisions.
This outlook underscores the delicate balance the Federal Reserve must maintain as it navigates a challenging economic landscape influenced by inflation, labor market strength, and evolving trade dynamics.


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 



